세니젠

188260KOSDAQ그외 기타 제품 제조업

42.9 / 100

Reference Date: 2026-06-10

Financial Score10.0 / 40

News Sentiment16.9 / 25

Momentum2.0 / 20

Disclosure14.0 / 15

AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Plunged 23.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Senigen is a food safety specialist company established in 2005, leveraging advanced molecular diagnostic technologies like PCR and NGS to provide comprehensive food safety solutions. It has developed key products such as Genelix (high-sensitivity PCR) and GeNext (world's first NGS panel for foodborne pathogen detection), and is expanding into cosmetics and microbiome industries.

Number of Employees

72people

Average Salary

55.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 7.854.0Point

PBR

8.68Industry Average 0.920.0Point

9.4x industry avg (risky)

ROE

-108.63Industry Average -16.543.5Point

6.6x industry avg (excellent)

Debt Ratio

153.31Industry Average 11.460.0Point

13.4x industry avg (risky)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼12.0% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲17.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -84.6% (declining, 2yr)

Detailed News Sentiment

2 totalPositive 1Neutral 1Negative 0Average Sentiment Score 67.5

Positive
박정웅 세니젠 대표 “‘레드 바이오’로 제2 창업...1500억 밸류 ...
세니젠의 박정웅 대표가 새로운 바이오 기술 '레드 바이오'를 통해 기업 가치를 1500억으로 성장시키는 제2 창업을 선언하며 긍정적인 전망을 제시했다.
Neutral
세니젠, 최대주주 지씨파트너스로 변경
세니젠의 최대주주 변경 소식은 지분 구조 변화를 알리지만, 직접적인 경영 영향은 제한적임을 시사한다.

Detailed Momentum

52-week position1.0Point

Near 52w low (10%, downtrend)

Current 1,620Won52-week high 2,73552-week low 1,484

1-month return0.0Point

1m -23.04% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

10 totalPositive 2Neutral 8Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-06-09
Neutral주식등의대량보유상황보고서(일반)2026-05-20
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-20
Neutral[기재정정]분기보고서 (2026.03)2026-05-15
Neutral분기보고서 (2026.03)2026-05-14